![Seema Bhan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seema Bhan
Consultor / Asesor en Exai Bio, Inc. .
Cargos activos de Seema Bhan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Exai Bio, Inc.
![]() Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Consultor / Asesor | 02/01/2023 | - |
Section 32 LLC
![]() Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Consultor / Asesor | - | - |
Historial de carrera de Seema Bhan
Antiguos cargos conocidos de Seema Bhan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Thrive Earlier Detection Corp.
![]() Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Inversor de Capital Privado | 09/01/2019 | 31/01/2023 |
Foundation Medicine GmbH
![]() Foundation Medicine GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Foundation Medicine GmbH is a German company that provides technical testing and analysis services. The company is based in Penzberg, Germany. | Inversor de Capital Privado | 01/01/2018 | 30/09/2019 |
Estadísticas
Internacional
Estados Unidos | 4 |
Alemania | 2 |
Operativa
Private Equity Investor | 2 |
Consultant / Advisor | 2 |
Sectorial
Finance | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Section 32 LLC
![]() Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Finance |
Foundation Medicine GmbH
![]() Foundation Medicine GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Foundation Medicine GmbH is a German company that provides technical testing and analysis services. The company is based in Penzberg, Germany. | Commercial Services |
Thrive Earlier Detection Corp.
![]() Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Health Technology |
Exai Bio, Inc.
![]() Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Technology Services |
- Bolsa de valores
- Insiders
- Seema Bhan
- Experiencia